Cost-Effectiveness of Hormone Replacement Therapy for Fracture Prevention in Young Postmenopausal Women: An Economic Analysis Based on a Prospective Cohort Study

By Fleurence R.   Torgerson D. J.   Reid D. M.  

Osteoporosis International, Vol. 13, Iss. 8, 2002-08 ,pp. : 637-643

Springer Publishing Company

Access to resources Recommend Favorite

Maximal and submaximal aerobic fitness in postmenopausal women: influence of hormone-replacement therapy

By Kowalchuk John M.   Petrella Robert J.   Paterson Donald H.   Stathokostas Liza  

Applied Physiology, Nutrition, and Metabolism, Vol. 33, Iss. 5, 2008-10 ,pp. : 922-928

NRC Research Press

Access to resources Recommend Favorite

The Prevention of Osteoporosis Using Sequential Low-Dose Hormone Replacement Therapy with Estradiol-17β and Dydrogesterone

By Lees B.   Stevenson J. C.  

Osteoporosis International, Vol. 12, Iss. 4, 2001-05 ,pp. : 251-258

Springer Publishing Company

Access to resources Recommend Favorite

Relation of myeloperoxidase promoter polymorphism and long‐term hormone replacement therapy to oxidized low‐density lipoprotein autoantibodies in postmenopausal women

By Mäkelä R.   Dastidar P.   Jokela H.   Jaakkola O.   Saarela M.   Punnonen R.   Lehtimäki T.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 66, Iss. 5, 2006-08 ,pp. : 371-384

Informa Healthcare

Access to resources Recommend Favorite

Lipid-modifying effects of rosuvastatin in postmenopausal women with hypercholesterolemia who are receiving hormone replacement therapy

By Shepherd James   Packard Chris   Littlejohn Thomas W.   Walker James   Stein Evan A.   Smith Karen   Kallend David   Blasetto James W.  

Current Medical Research and Opinion, Vol. 20, Iss. 10, 2004-10 ,pp. : 1571-1578

Informa Healthcare

Access to resources Recommend Favorite